Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 156 entries
View as:

A Clinical Study of KW-3357 in Patients With DIC

Phase: N/A Priority: Normal
NCT ID: NCT01384396 Org: User:
Start: 12/31/11 End: 04/30/13 Due: 04/30/14

A Study of KW-3357 in Congenital Antithrombin Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00938288 Org: User:
Start: 04/30/09 End: 04/30/11 Due: 04/30/12

Clinical Study of KHK7791 in Hyperphosphatemia Patients on Peritoneal Dialysis

Phase: N/A Priority: Normal
NCT ID: NCT04766385 Org: User:
Start: 03/03/21 End: 12/01/21 Due: 12/01/22

Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT00955526 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

Study of AMG531 (Romiplostim) in Patients With Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT04095936 Org: User:
Start: 12/03/19 End: 10/29/21 Due: 10/29/22

A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06248411 Org: User:
Start: 11/01/23 End: 04/30/30 Due: 04/30/31

A Comparative Study of KW-2246

Phase: N/A Priority: Normal
NCT ID: NCT01326689 Org: User:
Start: 03/31/11 End: 06/30/12 Due: 06/30/13

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03985189 Org: User:
Start: 04/29/19 End: 05/31/28 Due: 05/31/29

A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT00359840 Org: User:
Start: 07/31/06 End: - Due: -

Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT02773290 Org: User:
Start: 05/31/16 End: 07/28/20 Due: 07/28/21

Study of KHK2375 in Subjects With Advanced or Recurrent Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02623751 Org: User:
Start: 11/30/15 End: 10/31/20 Due: 10/31/21

A Phase 4 Clinical Study of Brodalumab

Phase: N/A Priority: Normal
NCT ID: NCT04183881 Org: User:
Start: 07/04/16 End: 07/24/17 Due: 07/24/18

A Study of KRN23 in Adult and Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia

Phase: N/A Priority: Normal
NCT ID: NCT04308096 Org: User:
Start: 01/09/18 End: 12/04/20 Due: 12/04/21

A Study to Evaluate Abuse Potential of Istradefylline

Phase: N/A Priority: Normal
NCT ID: NCT02609477 Org: User:
Start: 01/31/16 End: 07/31/16 Due: 07/31/17

Study of Combination Therapy With Mogamulizumab (KW-0761) and Nivolumab (ONO-4538/BMS-936558) in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02476123 Org: User:
Start: 06/30/15 End: 12/21/18 Due: 12/21/19

Phase 2 Study of KHK4577

Phase: N/A Priority: Normal
NCT ID: NCT02004119 Org: User:
Start: 11/30/13 End: 12/31/14 Due: 12/31/15

A Study of KK2269 in Adult Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06266299 Org: User:
Start: 01/18/24 End: 12/31/27 Due: 12/31/28

A Drug Interaction Study of KW-6356 and Clarithromycin or Rifampicin

Phase: N/A Priority: Normal
NCT ID: NCT04070495 Org: User:
Start: 08/27/19 End: 11/19/19 Due: 11/19/20

Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NHL)

Phase: N/A Priority: Normal
NCT ID: NCT04533581 Org: User:
Start: 09/17/20 End: 05/31/28 Due: 05/31/29

A Phase III Clinical Study of KW-2246 for Breakthrough Pain in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00684632 Org: User:
Start: 03/31/08 End: 04/30/09 Due: 04/30/10

A Study of RTA 402 in Chronic Kidney Disease (CKD) Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01574365 Org: User:
Start: 02/29/12 End: 11/30/13 Due: 11/30/14

Extended Long-Term Safety Study of KW-6500

Phase: N/A Priority: Normal
NCT ID: NCT01063621 Org: User:
Start: 01/31/10 End: 03/31/12 Due: 03/31/13

A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

Phase: N/A Priority: Normal
NCT ID: NCT00455507 Org: User:
Start: 03/31/07 End: 08/31/08 Due: 08/31/09

A Phase 2 Clinical Study of KHK4827

Phase: N/A Priority: Normal
NCT ID: NCT01748539 Org: User:
Start: 12/31/12 End: 09/30/13 Due: 09/30/14

A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00457782 Org: User:
Start: 04/30/07 End: 01/31/11 Due: 01/31/12